Clinical Trial

IV Lidocaine Infusion Versus Placebo for Pain Control in Staging Laparoscopy Cases

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 19, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
IV lidocaine infusion is being used as an analgesic adjunct, since we are a opioid depleted country we are using lidocaine to decrease opioid consumption and avoid the side effects such nausea, vomiting and respiratory depression associated with morphine consumption. We have given the option of rescue analgesia to the anesthetist if the clinical scenario demands.
Trial Details
NCT Number NCT07419815
Lead Sponsor Shaukat Khanum Memorial Cancer Hospital & Research Centre
Conditions Side Effects of Opoid Consumption
Enrollment 62 participants
Start Date 2025-12-03
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-19